Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Nohra Guy P
Relationship:   Director
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   19    
Direct Shares   10,292,949    

Indirect Shares

   31,541,253      
Direct Value   $216,706,954    

Indirect Value

   $224,987,676      
Total Shares   41,834,202      
Total Value   $441,694,631      


Rigel Pharmaceuticals Inc $11,703 Crucell Nv $0 Ellie Mae Inc $151,292,653 Aerie Pharmaceuticals Inc $55,145,510 Evofem Biosciences Inc $1,339,776 aTyr Pharma Inc $651,483 Sutro Biopharma Inc $8,265,829 Bioventus Inc. $0 Rigel Pharmaceuticals Inc $11,703 Crucell Nv $0 Ellie Mae Inc $151,292,653 Aerie Pharmaceuticals Inc $55,145,510 Evofem Biosciences Inc $1,339,776 aTyr Pharma Inc $651,483 Sutro Biopharma Inc $8,265,829 Bioventus Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    2    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 31.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            AVADEL Pharmaceuticals Plc AVDL N/A 2003-10-02 0 2003-10-02 6,443    Premium*  
            Rigel Pharmaceuticals Inc RIGL N/A 2004-08-20 9,593 2004-08-20 29,715    Premium*  
            Renovis Inc RNVS Director 2004-02-10 0 2004-02-10 42,240    Premium*  
            Crucell Nv CRXLY N/A 2004-05-25 6,436 2004-05-25 0    Premium*  
            Icagen Inc ICGN 10% Owner 2005-02-08 0 2005-02-08 2,135,003    Premium*  
            Cutera Inc CUTR Director 2005-08-15 0 2005-08-15 0    Premium*  
            Neurogesx Inc NGSX 10% Owner 2007-05-07 0 2007-05-07 1,735,673    Premium*  
            Acelrx Pharmaceuticals Inc ACRX Director 2011-02-16 0 2013-09-20 2,507,974    Premium*  
            Ellie Mae Inc ELLI 10% Owner 2011-04-20 1,528,363 2011-04-20 1,524,804    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 2013-07-01 0 2014-10-21 2,552,189    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2014-05-22 3,616,099 2013-10-30 0    Premium*  
            Trevena Inc TRVN 10% Owner 2014-02-05 0 2014-12-10 4,390,262    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 3,230,090    Premium*  
            Evofem Biosciences Inc EVFM Former 10% Owner 2015-12-30 1,339,776 2014-11-25 2,595,257    Premium*  
            Kalvista Pharmaceuticals Inc KALV Director 2015-04-14 0 2015-04-14 4,343,550    Premium*  
            aTyr Pharma Inc LIFE 10% Owner 2015-05-12 1,778,064 2015-05-12 0    Premium*  
            Allakos Inc. ALLK 10% Owner 2021-03-04 0 2021-03-04 6,448,053    Premium*  
            Sutro Biopharma Inc STRO 10% Owner 2018-10-01 1,944,901 2018-10-01 0    Premium*  
            Bioventus Inc. BVS Director 2023-08-16 69,717 2023-08-16 0    Premium*  
* Premium Members only  

Records found :    86         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ICGN Icagen Inc 10% Owner   –       –       •   2005-02-08 4 A $0.00 $0 I/I 2,135,003 2,135,003 -
NGSX Neurogesx Inc 10% Owner   –       –       •   2007-05-07 4 A $0.00 $0 I/I 1,735,673 1,735,673 0 -
ELLI Ellie Mae Inc 10% Owner   –       –       •   2011-04-20 4 A $0.00 $0 D/D 1,746,485 1,766,425 0 -
ELLI Ellie Mae Inc 10% Owner   –       –       •   2011-04-20 4 A $0.00 $0 I/I 22,064 1,768,549 0 -
ELLI Ellie Mae Inc 10% Owner   –       –       •   2011-04-20 4 S $6.00 $24,474 I/I (4,079) 1,524,804 0 -
ELLI Ellie Mae Inc 10% Owner   –       –       •   2011-04-20 4 S $6.00 $1,937,988 D/D (322,998) 1,528,363 0 -
ELLI Ellie Mae Inc 10% Owner   –       –       •   2011-04-20 4 OE $3.00 $3,117 I/I 1,039 1,810,734 0 -
ELLI Ellie Mae Inc 10% Owner   –       –       •   2011-04-20 4 OE $3.00 $246,879 D/D 82,293 1,850,842 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 B $14.00 $3,299,996 I/I 235,714 2,052,189 1.5 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2013-07-01 4 A $0.00 $0 I/I 1,816,475 1,816,475 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2013-10-30 4 A $0.00 $0 D/D 3,806,099 3,806,099 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2013-10-30 4 B $10.00 $1,100,000 D/D 110,000 3,916,099 2.45 -
TRVN Trevena Inc 10% Owner   –       –       •   2014-02-05 4 B $7.00 $3,306,870 I/I 472,410 3,890,262 1.5 -
TRVN Trevena Inc 10% Owner   –       –       •   2014-02-05 4 A $0.00 $0 I/I 3,417,852 3,417,852 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-05-22 4 S $16.00 $4,800,000 D/D (300,000) 3,616,099 0 -
ESPR Esperion Therapeutics, In... 10% Owner   –       –       •   2014-10-21 4 B $20.00 $10,000,000 I/I 500,000 2,552,189 1.5 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2014-11-25 4 B $14.00 $980,000 I/I 70,000 2,667,024 1.5 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2014-11-25 4 A $0.00 $0 I/I 2,497,647 2,501,581 0 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2014-11-25 4 OE $8.54 $2,347,595 I/I 244,729 2,618,453 0 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2014-11-25 4 S $14.00 $2,090,004 I/I (149,286) 2,597,024 0 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2014-11-25 4/A OE $8.54 $799,993 I/I 93,676 2,595,257 0 -
TRVN Trevena Inc 10% Owner   –       –       •   2014-12-10 4 B $4.00 $2,000,000 I/I 500,000 4,390,262 1.5 -
LIFE aTyr Pharma Inc 10% Owner   –       –       •   2015-05-12 4 A $0.00 $0 D/D 1,778,064 1,778,064 0 -
EVFM Evofem Biosciences Inc 10% Owner   –       –       •   2015-12-15 4 S $1.44 $762,136 D/D (529,261) 2,137,763 0 -
ALLK Allakos Inc. 10% Owner   –       –       •   2018-07-23 4 B $18.00 $4,500,000 I/I 250,000 11,519,200 1.5 -
  86  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us